DONATE TODAY
To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

May 23, 2024

SCHEDULE NOW: Meet with EBCI at ASCO

2024 ASCO

Schedule a Meeting with Us to Discuss How We Partner with CRO’s & Pharma

MAY 31 - JUNE 2, 2024 | CHICAGO, IL

The End Brain Cancer Initiative (EBCI) engages directly with healthcare professionals and companies in the brain cancer space in order to insert the patient voice into trial protocols and patient disease education and awareness campaigns. As part of this mission, we will be on-site in Chicago, IL from May 31st to June 2nd to attend the 2024 ASCO (American Society of Clinical Oncology) Annual Meeting.

Shawn Headshot e1629996588795
Shawn Drennan

Shawn Drennan, EBCI Treasurer and Head of Finance and Operations, will be on-site to meet with potential partners about our disease education, awareness, and outreach programs/services. EBCI Corporate and Collaborative Partners can leverage the initiative's expertise, network, and resources to amplify their education, awareness, outreach, and branding efforts related to brain cancer clinical trials, treatments, products, devices, or diagnostics.

These partnerships can contribute to shared objectives and create a meaningful impact on brain cancer care and research. Click the button below to view Shawn's calendar and set a meeting with her for Friday 5/31, Saturday 6/1, or Sunday 6/2 (Central Time) at the EBCI Booth.


Sponsor logos

Hand holding cell phone displaying app

EBCI App QR

Scan or click the QR code to download the App now!

ENDBRAINCANCER INITIATIVE | CHRIS ELLIOTT FUND

Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
DONATE
corporate partners
upcoming events
resources
About us
envelopephonemap-markerpointer-right
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram